Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Effect of lactational exposure of olanzapine on body weight of mice: a comparative study on neonates of both the sexes during post-natal development.

Mishra AC, Mohanty B.

J Psychopharmacol. 2010 Jul;24(7):1089-96. doi: 10.1177/0269881108100775. Epub 2009 Jan 22.

PMID:
19164496
2.

Effects of lactational exposure of olanzapine and risperidone on hematology and lymphoid organs histopathology: a comparative study in mice neonates.

Mishra AC, Mohanty B.

Eur J Pharmacol. 2010 May 25;634(1-3):170-7. doi: 10.1016/j.ejphar.2010.02.014. Epub 2010 Feb 20.

PMID:
20176014
3.

The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.

Fell MJ, Anjum N, Dickinson K, Marshall KM, Peltola LM, Vickers S, Cheetham S, Neill JC.

Psychopharmacology (Berl). 2007 Oct;194(2):221-31. Epub 2007 Jun 21.

PMID:
17581744
4.

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.

Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD.

J Clin Psychiatry. 2001 Apr;62(4):231-8.

PMID:
11379836
5.

Lactational exposure to atypical antipsychotic drugs disrupts the pituitary-testicular axis in mice neonates during post-natal development.

Mishra AC, Mohanty B.

J Psychopharmacol. 2010 Jul;24(7):1097-104. doi: 10.1177/0269881109348162. Epub 2010 Jan 15.

PMID:
20080927
6.

A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.

Roerig JL, Steffen KJ, Mitchell JE, Crosby RD, Gosnell BA.

J Clin Psychopharmacol. 2008 Feb;28(1):21-6. doi: 10.1097/jcp.0b013e3181613325.

PMID:
18204336
7.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
8.

Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.

Fell MJ, Neill JC, Anjum N, Peltola LM, Marshall KM.

J Psychopharmacol. 2008 Mar;22(2):182-6. doi: 10.1177/0269881107082287. Epub 2008 Feb 28.

PMID:
18308803
9.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
11.

Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.

Smith RC, Lindenmayer JP, Davis JM, Kelly E, Viviano TF, Cornwell J, Hu Q, Khan A, Vaidhyanathaswamy S.

J Clin Psychiatry. 2009 Nov;70(11):1501-13. doi: 10.4088/JCP.08m04446yel. Epub 2009 Oct 6.

PMID:
19814947
12.

A crossover study on lipid and weight changes associated with olanzapine and risperidone.

Su KP, Wu PL, Pariante CM.

Psychopharmacology (Berl). 2005 Dec;183(3):383-6. Epub 2005 Oct 21.

PMID:
16240162
13.

Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine.

Kalinichev M, Rourke C, Jones DN.

Behav Pharmacol. 2006 May;17(3):289-92.

PMID:
16572006
14.

Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them.

Park S, Sang Mee Hong, Il Sung Ahn, Sung Hoon Kim.

J Psychopharmacol. 2010 Jul;24(7):1105-14. doi: 10.1177/0269881109348167. Epub 2009 Dec 4.

PMID:
19965940
15.
16.

Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia.

Yasui-Furukori N, Saito M, Nakagami T, Sugawara N, Sato Y, Tsuchimine S, Furukori H, Kaneko S.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):537-40. doi: 10.1016/j.pnpbp.2010.02.014. Epub 2010 Feb 17.

PMID:
20170699
17.

Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.

Cooper GD, Harrold JA, Halford JC, Goudie AJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):428-36. Epub 2007 Sep 22.

PMID:
17933447
18.

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B.

J Clin Psychiatry. 2003 May;64(5):598-604.

PMID:
12755665
19.

Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.

Yoon S, Noh JS, Choi SY, Baik JH.

Biochem Biophys Res Commun. 2010 Mar 5;393(2):235-41. doi: 10.1016/j.bbrc.2010.01.108. Epub 2010 Feb 1.

PMID:
20117094
20.

Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.

Gebhardt S, Haberhausen M, Heinzel-Gutenbrunner M, Gebhardt N, Remschmidt H, Krieg JC, Hebebrand J, Theisen FM.

J Psychiatr Res. 2009 Mar;43(6):620-6. doi: 10.1016/j.jpsychires.2008.11.001. Epub 2008 Dec 24.

PMID:
19110264
Items per page

Supplemental Content

Write to the Help Desk